Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Müller-Wieland

Showing results (1-10 of 83) with videos related to

Pageof 9
Sort By:
Deutsche Medizinische Wochenschrift (1946)|April 29, 2010
[New, expensive antidiabetics for the treatment of type-2 diabetes--pro]D Müller-Wieland
Deutsche Medizinische Wochenschrift (1946)|May 8, 2009
[Diabetes and obesity--the complex phenotype]D Müller-Wieland
Der Internist|April 2, 2011
[Cardiovascular risk in type 2 diabetes. ACCORD study (Action to Control Cardiovascular Risk in Diabetes)]D Müller-Wieland, S Nitschmann
Herz|May 25, 2016
[PCSK9 inhibitors : New treatment option in clinical practice]D Müller-Wieland, N Marx
Handbook of Experimental Pharmacology|April 7, 2006
Correction of insulin resistance and the metabolic syndromeD Müller-Wieland, J Kotzka
Der Internist|July 1, 1994
[Rational lipid diagnosis]W Krone, D Müller-Wieland
Der Internist|February 25, 2017
[Diabetology as an interdisciplinary challenge]D Müller-Wieland, N Marx
Herz|March 15, 2014
[Lipid therapy for patients with coronary heart disease and diabetes. Current state and perspectives]D Müller-Wieland, M Merkel
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1991
[Drug therapy of high risk patients with diabetes mellitus]W Krone, D Müller-Wieland
Thrombosis and Haemostasis|March 1, 2000
Lipid lowering therapy and stabilization of atherosclerotic plaquesW Krone, D Müller-Wieland
Pageof 9

Showing results (1-10 of 83) with videos related to

Sort By:
Pageof 9
Deutsche Medizinische Wochenschrift (1946)|April 29, 2010
[New, expensive antidiabetics for the treatment of type-2 diabetes--pro]D Müller-Wieland
Deutsche Medizinische Wochenschrift (1946)|May 8, 2009
[Diabetes and obesity--the complex phenotype]D Müller-Wieland
Der Internist|April 2, 2011
[Cardiovascular risk in type 2 diabetes. ACCORD study (Action to Control Cardiovascular Risk in Diabetes)]D Müller-Wieland, S Nitschmann
Herz|May 25, 2016
[PCSK9 inhibitors : New treatment option in clinical practice]D Müller-Wieland, N Marx
Handbook of Experimental Pharmacology|April 7, 2006
Correction of insulin resistance and the metabolic syndromeD Müller-Wieland, J Kotzka
Der Internist|July 1, 1994
[Rational lipid diagnosis]W Krone, D Müller-Wieland
Der Internist|February 25, 2017
[Diabetology as an interdisciplinary challenge]D Müller-Wieland, N Marx
Herz|March 15, 2014
[Lipid therapy for patients with coronary heart disease and diabetes. Current state and perspectives]D Müller-Wieland, M Merkel
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1991
[Drug therapy of high risk patients with diabetes mellitus]W Krone, D Müller-Wieland
Thrombosis and Haemostasis|March 1, 2000
Lipid lowering therapy and stabilization of atherosclerotic plaquesW Krone, D Müller-Wieland
Pageof 9